» Articles » PMID: 2464941

Silent Somatotroph Adenomas of the Human Pituitary. A Morphologic Study of Three Cases Including Immunocytochemistry, Electron Microscopy, in Vitro Examination, and in Situ Hybridization

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1989 Feb 1
PMID 2464941
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Pituitary adenomas, removed surgically from three women with normal or slightly elevated serum growth hormone levels and no evidence of acromegaly, were studied. The tumor cells were shown by electron microscopy to correspond to sparsely granulated somatotrophs but immunocytochemistry showed that they contained no, moderate, or little growth hormone. Two tumors examined in vitro secreted small amounts of growth hormone in the tissue culture medium initially with a spontaneous rise after several days, and responded to growth hormone-releasing hormone stimulation with increased growth hormone release. In situ hybridization demonstrated growth hormone mRNA expression in adenoma cells. Clinically silent somatotroph adenomas represent a hitherto undescribed entity; electron microscopy shows that they consist of somatotrophs, and express growth hormone mRNA but do not secrete growth hormone in amounts needed to raise substantially serum growth hormone levels and cause acromegaly. Further work is required to clarify the mechanisms accounting for the lack of clinical and biochemical evidence of hormone excess associated with these tumors.

Citing Articles

Characteristics and treatment of a silent somatotroph tumor that had transformed to a functional type: a case report and literature review.

Li Z, Wu Y, Sun J, Wang R, Bao X Gland Surg. 2024; 13(7):1322-1330.

PMID: 39175709 PMC: 11336798. DOI: 10.21037/gs-24-79.


Surgery for acromegaly: Indications and goals.

Bray D, Mannam S, Rindler R, Quillin J, Oyesiku N Front Endocrinol (Lausanne). 2022; 13:924589.

PMID: 35992136 PMC: 9386525. DOI: 10.3389/fendo.2022.924589.


The silent variants of pituitary tumors: demographic, radiological and molecular characteristics.

Torregrosa-Quesada M, Garcia-Martinez A, Sanchez-Barbie A, Silva-Ortega S, Camara R, Fajardo C J Endocrinol Invest. 2021; 44(8):1637-1648.

PMID: 33476035 DOI: 10.1007/s40618-020-01468-2.


Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.

Mete O, Alshaikh O, Cintosun A, Ezzat S, Asa S Endocr Pathol. 2018; 29(4):332-338.

PMID: 30215160 DOI: 10.1007/s12022-018-9545-4.


Clinical and Pathological Aspects of Silent Pituitary Adenomas.

Drummond J, Roncaroli F, Grossman A, Korbonits M J Clin Endocrinol Metab. 2018; 104(7):2473-2489.

PMID: 30020466 PMC: 6517166. DOI: 10.1210/jc.2018-00688.


References
1.
DeLellis R, WOLFE H . Contributions of immunohistochemical and molecular biological techniques to endocrine pathology. J Histochem Cytochem. 1987; 35(11):1347-51. DOI: 10.1177/35.11.2443560. View

2.
Lloyd R . Use of molecular probes in the study of endocrine diseases. Hum Pathol. 1987; 18(12):1199-211. DOI: 10.1016/s0046-8177(87)80402-1. View

3.
Grody W, Cheng L, Lewin K . Application of in situ DNA hybridization technology to diagnostic surgical pathology. Pathol Annu. 1987; 22 Pt 2:151-75. View

4.
Kovacs K, Horvath E . Pathology of pituitary tumors. Endocrinol Metab Clin North Am. 1987; 16(3):529-51. View

5.
U H, KELLEY P, Lee W . Abnormalities of the human growth hormone gene and protooncogenes in some human pituitary adenomas. Mol Endocrinol. 1988; 2(1):85-9. DOI: 10.1210/mend-2-1-85. View